Today: 19 March 2026
Browse Category

ASX:QBE 27 November 2025 - 4 March 2026

ASX Week Ahead: CPI Day and a Flood of Big Earnings Put Australian Shares to the Test

ASX Week Ahead: CPI Day and a Flood of Big Earnings Put Australian Shares to the Test

The S&P/ASX 200 closed at 9,081.4 on Friday, just below Thursday’s record, after banks posted stronger-than-expected earnings. Rio Tinto dropped up to 4% after missing profit estimates, while QBE Insurance surged 6% on a profit beat. Key earnings from Woodside, Woolworths, Qantas, and Coles are due next week. January inflation data on Wednesday is expected to influence rate expectations.
QBE Insurance Group Limited (ASX:QBE) Stock Update: Buyback Kickoff, Climate Strategy Shift, and the Week Ahead (Updated 14 Dec 2025)

QBE Insurance Group Limited (ASX:QBE) Stock Update: Buyback Kickoff, Climate Strategy Shift, and the Week Ahead (Updated 14 Dec 2025)

QBE shares closed at A$19.37 on Friday, up 2.9% for the week ending 12 December 2025. The insurer will begin a A$450 million on-market buyback, set to run through December 2026. Gross written premium rose 6% year-to-date, but premium rate increases slowed to 1.5%. Board changes and a climate strategy update are also pending.
14 December 2025
QBE Insurance Group Limited (ASX:QBE) Stock: Buyback Starts, Fresh Strategy Signals, and Updated Analyst Forecasts (Dec 13, 2025)

QBE Insurance Group Limited (ASX:QBE) Stock: Buyback Starts, Fresh Strategy Signals, and Updated Analyst Forecasts (Dec 13, 2025)

QBE shares closed at A$19.37 on Friday, above their late-November low after the company reported slower premium-rate growth. The insurer has begun a buyback of up to A$450 million, with JP Morgan Securities as broker, running through December 2026. Investors remain focused on whether QBE can maintain margins as premium momentum cools.
13 December 2025

Stock Market Today

  • GBT.PA Guerbet SA surges 10% intraday on EURONEXT; mixed technical and fundamental signals
    March 19, 2026, 10:45 AM EDT. GBT.PA stock of Guerbet SA jumped 10% intraday on March 19, 2026, reaching €9.24 on EURONEXT, backed by increased volume of 13,540 shares. The rise contrasts with a challenging fundamental backdrop including a negative earnings per share of -8.93 and a debt-to-equity ratio above 1. Meyka AI assigned a HOLD rating with a price target of €18.13, suggesting near 96% upside. Technical indicators signal oversold conditions but face resistance at the 50-day (€13.27) and 200-day (€16.76) averages. Risks include deep value from price-to-book 0.31 and interest coverage issues. Analysts recommend cautious positions with tight stops, eyeing upcoming earnings and sector dynamics in European Healthcare device stocks.
Go toTop